The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

2018
journal article
article
3
dc.affiliationWydział Lekarski : Klinika Chorób Zakaźnych i Tropikalnychpl
dc.cm.date2020-01-07
dc.cm.id92082
dc.contributor.authorJanczewska, Ewapl
dc.contributor.authorZarębska-Michaluk, Dorotapl
dc.contributor.authorBerak, Hannapl
dc.contributor.authorPiekarska, Annapl
dc.contributor.authorGietka, Andrzejpl
dc.contributor.authorDybowska, Dorotapl
dc.contributor.authorMazur, Włodzimierzpl
dc.contributor.authorBelica-Wdowik, Teresapl
dc.contributor.authorDobracki, Witoldpl
dc.contributor.authorTudrujek-Zdunek, Magdalenapl
dc.contributor.authorDeroń, Zbigniewpl
dc.contributor.authorBuczyńska, Iwonapl
dc.contributor.authorSitko, Marekpl
dc.contributor.authorCzauz-Andrzejuk, Agnieszkapl
dc.contributor.authorLorenc, Beatapl
dc.contributor.authorBiałkowska-Warzecha, Jolantapl
dc.contributor.authorCitko, Jolantapl
dc.contributor.authorLaurans, Łukaszpl
dc.contributor.authorJaroszewicz, Jerzypl
dc.contributor.authorSocha, Łukaszpl
dc.contributor.authorTronina, Olgapl
dc.contributor.authorAdamek, Brygidapl
dc.contributor.authorHorban, Andrzejpl
dc.contributor.authorHalota, Waldemarpl
dc.contributor.authorBaka- Ćwierz, Barbarapl
dc.contributor.authorTomasiewicz, Krzysztofpl
dc.contributor.authorSimon, Krzysztofpl
dc.contributor.authorGarlicki, Aleksander - 129452 pl
dc.contributor.authorWawrzynowicz-Syczewska, Martapl
dc.contributor.authorFlisiak, Robertpl
dc.date.accessioned2020-01-17T10:02:46Z
dc.date.available2020-01-17T10:02:46Z
dc.date.issued2018pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number1pl
dc.description.points30pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume18pl
dc.identifier.articleid580pl
dc.identifier.doi10.1186/s12879-018-3465-2pl
dc.identifier.eissn1471-2334
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/144727
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa*
dc.rights.licenceCC-BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subtypeArticlepl
dc.titleThe efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort studypl
dc.title.journalBMC Infectious Diseasespl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Lekarski : Klinika Chorób Zakaźnych i Tropikalnych
dc.cm.date
2020-01-07
dc.cm.id
92082
dc.contributor.authorpl
Janczewska, Ewa
dc.contributor.authorpl
Zarębska-Michaluk, Dorota
dc.contributor.authorpl
Berak, Hanna
dc.contributor.authorpl
Piekarska, Anna
dc.contributor.authorpl
Gietka, Andrzej
dc.contributor.authorpl
Dybowska, Dorota
dc.contributor.authorpl
Mazur, Włodzimierz
dc.contributor.authorpl
Belica-Wdowik, Teresa
dc.contributor.authorpl
Dobracki, Witold
dc.contributor.authorpl
Tudrujek-Zdunek, Magdalena
dc.contributor.authorpl
Deroń, Zbigniew
dc.contributor.authorpl
Buczyńska, Iwona
dc.contributor.authorpl
Sitko, Marek
dc.contributor.authorpl
Czauz-Andrzejuk, Agnieszka
dc.contributor.authorpl
Lorenc, Beata
dc.contributor.authorpl
Białkowska-Warzecha, Jolanta
dc.contributor.authorpl
Citko, Jolanta
dc.contributor.authorpl
Laurans, Łukasz
dc.contributor.authorpl
Jaroszewicz, Jerzy
dc.contributor.authorpl
Socha, Łukasz
dc.contributor.authorpl
Tronina, Olga
dc.contributor.authorpl
Adamek, Brygida
dc.contributor.authorpl
Horban, Andrzej
dc.contributor.authorpl
Halota, Waldemar
dc.contributor.authorpl
Baka- Ćwierz, Barbara
dc.contributor.authorpl
Tomasiewicz, Krzysztof
dc.contributor.authorpl
Simon, Krzysztof
dc.contributor.authorpl
Garlicki, Aleksander - 129452
dc.contributor.authorpl
Wawrzynowicz-Syczewska, Marta
dc.contributor.authorpl
Flisiak, Robert
dc.date.accessioned
2020-01-17T10:02:46Z
dc.date.available
2020-01-17T10:02:46Z
dc.date.issuedpl
2018
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
1
dc.description.pointspl
30
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
18
dc.identifier.articleidpl
580
dc.identifier.doipl
10.1186/s12879-018-3465-2
dc.identifier.eissn
1471-2334
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/144727
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa
dc.rights.licence
CC-BY
dc.rights.uri*
http://creativecommons.org/licenses/by/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subtypepl
Article
dc.titlepl
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study
dc.title.journalpl
BMC Infectious Diseases
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
8
Views per month
Views per city
Ashburn
3
Wroclaw
2
Des Moines
1
Dublin
1
Szczecin
1
Downloads
garlicki_et-al_the_efficacy_of_paritaprevir_2018.pdf
21
garlicki_et-al_the_efficacy_of_paritaprevir_2018.odt
6